Close

Form N-CEN Capital Group Central For: May 31

August 15, 2022 2:44 PM EDT


  X0404
  
    N-CEN
    
      LIVE
      
        
          0001841440
          XXXXXXXX
        
      
      
        true
        false
        false
      
      N-1A
    
    
      
        true
      
    
  
  
    
    
      Capital Group Central Fund Series II
      811-23633
      0001841440
      549300UY3V0C1Q1DAW77
      6455 Irvine Center Drive
      Irvine
      92618
      US-CA
      US
      9499755000
      
        
      
      
        
          Capital Research and Management Company
          6455 Irvine Center Drive
          Irvine
          
          92618
          9499755000
          Fund accounting and transaction settlement records
        
      
      N
      N
      
      N-1A
      1
      N
      
        
          Alexandra Trower
          N/A
          N
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
        
          Francisco G. Cigarroa
          N/A
          N
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
        
          James G. Ellis
          N/A
          N
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
        
          Karl J. Zeile
          N/A
          Y
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
        
          Margaret Spellings
          N/A
          N
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
        
          Mary Davis Holt
          N/A
          N
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
        
          Merit E. Janow
          N/A
          N
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
        
          Mike C. Gitlin
          N/A
          Y
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
        
          Nariman Farvardin
          N/A
          N
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
        
          Paul S. Williams
          N/A
          N
          
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
            
          
        
      
      
        
          Jane M. Scofield
          N/A
          333 South Hope Street
          55th
          Los Angeles
          
          90071
          XXXXXX
          N
          
            
          
        
      
      N
      N
      N
      N
      
      N
      
        
      
      
        
          American Funds Distributors, Inc.
          8-17168
          000006247
          N/A
          
          Y
        
      
      N
      
        
          PricewaterhouseCoopers LLP
          00238
          5493002GVO7EO8RNNS37
          
        
      
      N
      N
      N
      N
      N
      N
      N
    
    
      
        Capital Group Central Corporate Bond Fund
        S000071511
        549300UY3V0C1Q1DAW77
        N
        1
        0
        0
        
          
        
        N/A
        N
        N
        N
        N
        N/A
        N/A
        N/A
        
          Rule 12d1-1 (17 CFR 270.12d1-1)
          Rule 17a-7 (17 CFR 270.17a-7)
          Rule 32a-4 (17 CFR 270.32a-4)
          Rule 12d1-4 (17 CFR 270.12d1-4)
          Rule 18f-4 (17 CFR 270.18f-4)
        
        N
        N
        N
        N
        
          
            Capital Research and Management Company
            801-8055
            000110885
            M02M7XSKLMK96MWKNF95
            
            N
          
        
        
          
            American Funds Service Company
            84-00316
            N/A
            
            Y
            N
          
        
        N
        
          
            Refinitiv US LLC
            213800HQORQAP68CJJ04
            
            N
          
          
            Six Financial Information AG
            506700D369548LQDC335
            CH
            N
          
          
            Bloomberg L.P.
            549300B56MD0ZC402L06
            
            N
          
          
            ICE Data Pricing & Reference Data, LLC
            5493000NQ9LYLDBCTL34
            
            N
          
          
            PricingDirect Inc.
            549300WIC0TOJ7N7GD54
            
            N
          
          
            Virtu ITG Solutions Network, LLC
            N/A
            
            N
          
          
            Markit North America, Inc.
            549300HLPTRASHS0E726
            
            N
          
        
        N
        
          
            State Street Bank and Trust Co.
            N/A
            
            N
            N
            Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1))
          
        
        N
        
          
            American Funds Service Company
            84-00316
            SEC File number
            
            Y
            N
          
        
        N
        
          
            Capital Research and Management Company
            M02M7XSKLMK96MWKNF95
            
            Y
            N
          
        
        N
        
          
            American Funds Distributors, Inc.
            8-17168
            000006247
            N/A
            
            0.0
          
        
        0.000000000000
        
          
            Goldman Sachs & Co. LLC
            8-00129-1
            000000361
            FOR8UP27PHTHYVLBNG30
            
            3993953140.000000000000
          
          
            Bank of America, N.A.
            8-69787-1
            000283942
            B4TYDEB6GKMZO031MB27
            
            3358413330.000000000000
          
          
            Morgan Stanley & Co. LLC
            8-15869-1
            000008209
            9R7GPTSO7KV3UQJZQ078
            
            3024481066.000000000000
          
          
            J.P. Morgan Securities LLC
            8-35008-1
            000000079
            ZBUT11V806EZRVTWT807
            
            2954490037.000000000000
          
          
            Citigroup Global Markets Inc.
            8-08177-1
            000007059
            MBNUM2BPBDO7JBLYG310
            
            2414004413.000000000000
          
          
            Barclays Bank PLC
            N/A
            N/A
            G5GSEF7VJP5I7OUK5573
            GB
            1711191564.000000000000
          
          
            Wells Fargo Securities, LLC
            8-65876-1
            000126292
            VYVVCKR63DVZZN70PB21
            
            1580649258.000000000000
          
          
            Deutsche Bank A.G.
            N/A
            N/A
            7LTWFZYICNSX8D621K86
            DE
            1187550243.000000000000
          
          
            RBC Capital Markets LLC
            8-45411-1
            000031194
            549300LCO2FLSSVFFR64
            
            1161442339.000000000000
          
          
            BNP Paribas
            N/A
            N/A
            R0MUWSFPU8MPRO8K5P83
            FR
            1016071129.000000000000
          
        
        26400763103.000000000000
        N
        14561793940.000000000000
        
          
            
              Uncommitted
              1500000000.000000000000
              
                
              
              
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
              
              N
            
          
        
        N
        N
        N
      
    
    
    
      true
    
    
  



 
 

Report of Independent Registered Public Accounting Firm

To the Board of Trustees of Capital Group Central Fund Series II and Shareholders of Capital Group Central Corporate Bond Fund

In planning and performing our audit of the financial statements of Capital Group Central Corporate Bond Fund (constituting Capital Group Central Fund Series II, referred to hereafter as the "Fund") as of and for the year ended May 31, 2022, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of May 31, 2022.

This report is intended solely for the information and use of the Board of Trustees of Capital Group Central Fund Series II and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

Los Angeles, California

July 13, 2022

PricewaterhouseCoopers LLP, 601 South Figueroa Street, Los Angeles, CA 90017 T: (213) 356-6000, F: (813) 637 4444, www.pwc.com/us



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings